Fox Chase Cancer Center News

PHILADELPHIA (May 1, 2016) — Many patients with breast or ovarian cancer initially benefit from DNA-damaging chemotherapies, but it has not been clear why these treatments lose effectiveness over time. In a new study, Fox Chase Cancer Center researchers showed that patients with mutations affecting a specific portion of the BRCA1 gene were susceptible to a new pathway of resistance to DNA-damaging drugs, including PARP inhibitors and platinum compounds.

PHILADELPHIA (April 25, 2016) — Faculty, staff, volunteers, patients, survivors, and their families and friends will come together as members of the Fox Chase Cancer Center-Temple Health team at Susan G. Komen Philadelphia’s 26th Annual Race for the Cure on Mother’s Day — Sunday, May 8, 2016.

PHILADELPHIA (April 22, 2016) – Lymphoma Workshop: Understanding Lymphoma Basics and Current Treatment Options, will be on May 7, 2016, at the Sheraton Philadelphia Downtown Hotel in Philadelphia, Pennsylvania.

Scanning over 14,000 neighborhood variables from the U.S. Census for associations with prostate cancer aggressiveness, the study identified 17 neighborhood variables that were most significantly associated with advanced prostate cancer in white men.   

PHILADELPHIA (April 12, 2016) — In a unanimous vote by the council and general membership, Fisher was voted in as an honorary member and Chernoff was elected as an active member. Just seven new members were elected to the club this year.

PHILADELPHIA (April 11, 2016) — Fox Chase Cancer Center hosted its Annual Volunteer Recognition Luncheon on Friday, April 8, 2016, honoring volunteers for their hard work and dedication to the Center, its faculty, patients and families.

PHILADELPHIA (April 8, 2016) — Rosaleen B. Parsons, MD, FACR,  chair of diagnostic imaging at Fox Chase Cancer Center, has been elected an SAR fellow in recognition of significant contributions to the field.